Healthcare Jan 26, 2022 03:59 AM (GMT+8) · EqualOcean
From the end of 2021 to the beginning of January 2022, the A-share traditional Chinese medicine sector continued to be hot, and ushered in the limit tide for several trading days. Behind this is the frequent emergence of traditional Chinese medicine policies at the national level, the centralized collection and landing of traditional Chinese medicine, and the prominent role of traditional Chinese medicine in the epidemic in recent years, especially since 2021. In the near future, the correction of traditional Chinese medicine plate has attracted the attention of relevant parties. Many experts said that in the medium and long term, traditional Chinese medicine will develop stably in the future. Other experts pointed out that traditional Chinese medicine enterprises should be good at using the cash flow of the traditional Chinese medicine industry to invest in drug research and development, break through the shackles and shackles of traditional Chinese medicine and other traditional industries, create a "moat" and more stimulate the endogenous development power of the industry.

This text is a result of machine translation.